Table of Content - Basal Cell Carcinoma Market

Basal cell carcinoma is a type of skin cancer. Basal cell carcinoma begins in the basal cells a type of cell within the skin that produces new skin cells as old ones die off. Basal cell carcinoma often appears as a slightly transparent bump on the skin, though it can take other forms. Basal cell carcinoma occurs most often on areas of the skin that are exposed to the sun, such as head and neck. It is more common among fair-skinned people with sun exposure and is very rare among dark-skinned people.

Market Dynamics

Key players operating in the global basal cell carcinoma market are focusing on adoption of growth strategies such as product launch, regulatory approval, and research and development for the treatment of basal cell carcinoma, which is expected to drive the market growth during the forecast period. For instance, in January 2021, Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, announced dose administration for the first patient in a phase 2a clinical study of the company's lead drug candidate, STP705, for the treatment of cutaneous basal cell carcinoma. Moreover, in November 18 2021, Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that the U.S. Food and Drug Administration had accepted the company’s investigational new drug application for LTX-315, a potential first-in-class oncolytic peptide, for the treatment of basal cell carcinoma. The company expects to initiate its phase II trial of LTX-315 in basal cell carcinoma in the first quarter of 2022.

Key features of the study

This report provides in-depth analysis of the global basal cell carcinoma market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global basal cell carcinoma market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Novartis AG., Bausch & Lomb Incorporated., Allergan, Perrigo Company plc, Taro Pharmaceutical Industries Ltd., Provectus Biopharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Sanofi, and Mylan N.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global basal cell carcinoma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global basal cell carcinoma market

Market Segmentation

By Treatment Type (Revenue, USD Bn, 2021-2033)
- Surgical
  - Surgical Excision
  - Electrodessication & Cutterage ED&C
  - Moh's Surgery
  - Cryosurgery
- Drugs
  - Topical Treatment
  - Advanced Medication
  - Other
- Others
  - Radiation Therapy
  - Photodynamic Therapy PDT
  - Laser Therapy
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Specialty Clinics
- Others
Global Basal Cell Carcinoma Market, By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Merck & Co., Inc.
- Sun Pharmaceutical Industries Ltd.
- Novartis AG.
- Bausch & Lomb Incorporated.
- Allergan
- Perrigo Company plc
- Taro Pharmaceutical Industries Ltd.
- Provectus Biopharmaceuticals, Inc.
- Hoffmann-La Roche Ltd
- Sanofi
- Mylan N.V.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Treatment Type
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global Basal Cell Carcinoma Market, By Treatment Type, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Surgical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  - Segment Trends
    - Surgical Excision
    - Electrodessication & Cutterage ED&C
    - Moh's Surgery
    - Cryosurgery
- Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  - Segment Trends
    - Topical Treatment
    - Advanced Medication
    - Other
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  - Segment Trends
    - Radiation Therapy
    - Photodynamic Therapy PDT
    - Laser Therapy
Global Basal Cell Carcinoma Market, By End User, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Global Basal Cell Carcinoma Market, By Region, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Novartis AG.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Bausch & Lomb Incorporated.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Allergan
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Perrigo Company plc
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Taro Pharmaceutical Industries Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Provectus Biopharmaceuticals, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - F. Hoffmann-La Roche Ltd
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Mylan N.V.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE